In an article called, “Trump coaxes big promises from big pharma,” Jane is quoted on the recent announcements from pharma companies who are reducing certain prescription drug prices through the end of 2018. ‘This is not a policy, this is self-regulation – these are ad hoc agreements that are verbal and can change,’ Jane explained. Check out the in-depth analysis by Rebecca Trager.
Jane quoted in Royal Society of Chemistry journal on President Trump’s prescription drug pricing policy
By Jane Sarasohn-Kahn on 25 July 2018 in
I was invited to be a Judge for the upcoming CES 2025 Innovation Awards in the category of digital health and connected fitness. So grateful to be part of this annual effort to identify the best in consumer-facing health solutions for self-care, condition management, and family well-being. Thank you, CTA!
Thank you Team Roche for inviting me to brainstorm patients as health citizens, consumers, payers, and voters in the Healthcare Transformers series.
For the past 15 years, the annual CES conference in Las Vegas has been my go-to meeting for updating my research and network in digital health and consumer-facing electronics that people find meaningful for their well-being, families, and home lives. I'll be back in Vegas in January for a full week of Media Days, one-on-one meetings, and speaking about my perspectives on health consumers.